Taurine Market Size, Share & Analysis Report, 2022-2030
According to Nova one advisor, the global Taurine market size is expected to hit around USD 0.4 billion by 2030 from valued at USD 0.3 billion in 2021 and growing at a CAGR of 6.3% from 2022 to 2030.
Taurine Market: Overview
Report Scope of the Taurine Market
|
Report Coverage |
Details |
|
Market Size |
USD 0.4 Billion by 2030 |
|
Growth Rate |
CAGR of 6.3% from 2022 to 2030 |
|
Largest Market |
North America |
|
Fastest Growing Market |
Asia Pacific |
|
Base Year |
2021 |
|
Forecast Period |
2022 to 2030 |
|
Segments Covered |
Type, Application, Form And Geography, |
|
Companies Mentioned |
|
Taurine Market: Key Segments
Taurine Makes Trailblazing Entry in Pet Food Segment
The high prevalence of taurine deficiency in cats and dogs is fueling the demand for nutritious pet food innovations. Celebrity endorsements for pet food products in India through eCommerce and traditional media are translating into value-grab opportunities for brands in the taurine market.
Taurine is being publicized as an essential amino acid, which helps to maintain healthy heart and improves eyesight of cats and dogs. Brands in the taurine market are capitalizing on this opportunity to bolster their output capacities, as omega 3 & 6 fatty acids keep the coat beautiful and lustrous. The blend of organic minerals, along with taurine and other ingredients helps to control urinary pH. Thus, pet food manufacturers are increasing the production of prebiotics and probiotics to protect cats from hairball formation and keep their digestive system healthy.
Healthcare and Pet Food Products Ensure Business Continuity amid COVID-19 Crisis
Manufacturers in the taurine market are increasing local production capabilities to reduce dependence on other countries for raw materials and other products during the ongoing COVID-19 crisis. They are maintaining optimum inventory levels to ensure business continuity and robust supply chains.
Companies in the taurine market are focusing on mission-critical applications such as increasing availability of healthcare products and pet food and beverages (F&B) among health- and pet-conscious consumers. Market stakeholders are establishing a balanced relationship with suppliers and ecosystem partners to keep the economies running. They are unlocking potentials in eCommerce for increasing the uptake of healthcare products, pet food, and beverage items. Participants in the market are drawing an analysis to understand their high-risk clients and customers where recovery of debt may be an issue.
Is Taurine Safe in Supplements and Energy Drinks for Pregnant Women?
Energy drinks are generating revenue opportunities for manufacturers in the taurine market. Taurine is gaining popularity as an essential amino acid, which is naturally found in animal-based foods such as meat and dairy. These foods help to support neurological development among individuals. Even though it is safe for consumption in food, there is a lack of evidence about the effects of taurine during pregnancy in supplement form and when combined with energy drinks. Hence, manufacturers are diversifying production activities in healthcare and pet food to generate new income sources.
Manufacturers are increasing the production of pharmaceutical and food grade taurine to expand revenue streams in healthcare and pet food products.
Pharmaceutical Secondary Standards for End Applications Aid in Quality Control
Apart from food products, manufacturers in the taurine market are tapping revenue opportunities in cleaning products, cosmetics, and flavors, among other applications. Companies are presenting Certified Reference Material (CRM) for food and pharmaceutical grade taurine, which is in accordance with ISO (International Organization for Standardization) standards. Certified pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost effective alternative to pharmacopoeia primary standards.
Secondary standards for pharmaceutical applications are suitable for use in several analytical applications, including, but not limited to, pharma release testing, F&B quality control testing, and pharma method development for qualitative and quantitative analyses. Such findings are contributing to the growth of the taurine market.
Taurine-based Technology in Hair Products Helps Maintain Styling
Brands are making use of taurine in hair products to meet demanding needs of women. In order to achieve this, companies are investing in R&D to advance in taurine-based technology that can be used to create wavy effects even with very straight hair, thus offering results that last for over a month. Innovative hair products are helping women to achieve natural movement in the hair, without affecting the quality of the fiber, whilst enhancing consumer experience such as smell & setting time.
An increasing number of women are opting for modern salon services to unlock creativity in hairstyles whilst taking care of the hair fiber. Such trends are creating revenue opportunities for taurine manufacturers.
Some of the prominent players in the Taurine Market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2030. For this study, Nova one advisor, Inc. has segmented the global Taurine market
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Key Benefits for Stakeholders
Chapter 1. Introduction
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Taurine Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Taurine Market Analysis and Forecast, 2017–2030
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Qualitative Information of different applications, forms & types of taurine in Global market
5.2. Overview of Clinical Trials Data on Taurine
5.3. Regulatory Scenario by Region/globally
5.4. COVID-19 Pandemic Impact on Industry (value chain and / mid / long term impact)
6. Global Taurine Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2030
6.3.1. Food Grade
6.3.2. Pharmaceutical Grade
6.4. Market Attractiveness Analysis, by Type
7. Global Taurine Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2030
7.3.1. Health Care Products
7.3.2. Pet Food
7.3.3. Beverage
7.3.4. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Taurine Market Analysis and Forecast, by Form
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Form, 2017–2030
8.3.1. Tablets/Capsules
8.3.2. Liquid-based Serum
8.3.3. Others
8.4. Market Attractiveness Analysis, by Form
9. Global Taurine Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Country/Region
10. North America Taurine Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017–2030
10.2.1. Food Grade
10.2.2. Pharmaceutical Grade
10.3. Market Value Forecast, by Application, 2017–2030
10.3.1. Health Care Products
10.3.2. Pet Food
10.3.3. Beverage
10.3.4. Others
10.4. Market Value Forecast, by Form, 2017–2030
10.4.1. Tablets/Capsules
10.4.2. Liquid-based Serum
10.4.3. Others
10.5. Market Value Forecast, by Country, 2017–2030
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By Form
10.6.4. By Country
11. Europe Taurine Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2030
11.2.1. Food Grade
11.2.2. Pharmaceutical Grade
11.3. Market Value Forecast, by Application, 2017–2030
11.3.1. Health Care Products
11.3.2. Pet Food
11.3.3. Beverage
11.3.4. Others
11.4. Market Value Forecast, by Form, 2017–2030
11.4.1. Tablets/Capsules
11.4.2. Liquid-based Serum
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2017–2030
11.5.1. U.K.
11.5.2. Germany
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By Form
11.6.4. By Country/Sub-region
12. Asia Pacific Taurine Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2030
12.2.1. Food Grade
12.2.2. Pharmaceutical Grade
12.3. Market Value Forecast, by Application, 2017–2030
12.3.1. Health Care Products
12.3.2. Pet Food
12.3.3. Beverage
12.3.4. Others
12.4. Market Value Forecast, by Form, 2017–2030
12.4.1. Tablets/Capsules
12.4.2. Liquid-based Serum
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2017–2030
12.5.1. China
12.5.2. India
12.5.3. Japan
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By Form
12.6.4. By Country/Sub-region
13. Latin America Taurine Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2030
13.2.1. Food Grade
13.2.2. Pharmaceutical Grade
13.3. Market Value Forecast, by Application, 2017–2030
13.3.1. Health Care Products
13.3.2. Pet Food
13.3.3. Beverage
13.3.4. Others
13.4. Market Value Forecast, by Form, 2017–2030
13.4.1. Tablets/Capsules
13.4.2. Liquid-based Serum
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2017–2030
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By Form
13.6.4. By Country/Sub-region
14. Middle East & Africa Taurine Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2030
14.2.1. Food Grade
14.2.2. Pharmaceutical Grade
14.3. Market Value Forecast, by Application, 2017–2030
14.3.1. Health Care Products
14.3.2. Pet Food
14.3.3. Beverage
14.3.4. Others
14.4. Market Value Forecast, by Form, 2017–2030
14.4.1. Tablets/Capsules
14.4.2. Liquid-based Serum
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2017–2030
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By Form
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix
15.2. Market Share Analysis, by Company, 2020
15.3. Competitive Business Strategies
15.4. Company Profiles
15.4.1. Taisho Pharmaceutical Holdings Co., Ltd.
15.4.1.1. Company Description
15.4.1.2. Business Overview
15.4.1.3. Financial Overview
15.4.1.4. SWOT Analysis
15.4.2. Grand Pharmaceutical Group Limited
15.4.2.1. Company Description
15.4.2.2. Business Overview
15.4.2.3. Financial Overview
15.4.2.4. SWOT Analysis
15.4.3. AWI-Awell Ingredients Co., Ltd.
15.4.3.1. Company Description
15.4.3.2. SWOT Analysis
15.4.4. The Honjo Chemical Corporation
15.4.4.1. Company Description
15.4.4.2. SWOT Analysis
15.4.5. Qianjiang Yongan Pharmaceutical Co., Ltd.
15.4.5.1. Company Description
15.4.5.2. Business Overview
15.4.5.3. SWOT Analysis
15.4.6. A. B. Enterprises
15.4.6.1. Company Description
15.4.6.2. SWOT Analysis
15.4.7. Atlantic Chemicals Trading GmbH
15.4.7.1. Company Description
15.4.7.2. SWOT Analysis
15.4.8. Kyowa Hakko Bio Co., Ltd.
15.4.8.1. Company Description
15.4.8.2. SWOT Analysis
15.4.9. Jiangsu Yuanyang Pharmaceutical Co., Ltd.
15.4.9.1. Company Description
15.4.9.2. SWOT Analysis
15.4.10. Hubei Grand Fuchi Pharmaceutical & Chemicals Co., Ltd.
15.4.10.1. Company Description
15.4.10.2. SWOT Analysis
15.4.11. Advance Inorganics
15.4.11.1. Company Description
15.4.11.2. SWOT Analysis
15.4.12. Aakriti Trading Company
15.4.12.1. Company Description
15.4.12.2. SWOT Analysis
15.4.13. Avanscure Lifesciences Pvt. Ltd.
15.4.13.1. Company Description
15.4.13.2. SWOT Analysis
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers